“…One recently published study, however, did suggests that gender is a characteristic that could modify the relation of poor sleep to inflammatory biomarkers, but due to small number of men and women in the sample, the investigators indicated that they were not able to test this association (Hong, et al, 2005). In light of the evidence from epidemiological studies for gender-specific association in sleep and healthy outcomes, and the fact that individual differences in sleep quality and quantity have been associated with putative mechanisms of cardiovascular and metabolic disease, the current observational study examined whether gender significantly moderates the relation of symptoms of disturbed sleep to markers of psychosocial distress and pathophysiological mechanisms in a large sample of men and women (Trenell, et al, 2007). Guided by previous observations, selection of biological and psychosocial markers was based on prior evidence indicating that elevations in levels of inflammatory (C-reactive protein (CRP) and interleukin (IL)-6) (Pradhan, et al, 2001;Ridker & Morrow, 2003), coagulation (fibrinogen) (Fibrinogen Studies, 2007;Temelkova-Kurktschiev, et al, 2002) and metabolic (fasting insulin, glucose and insulin resistance) (Arad, et al, 2001;Yanase, et al, 2004) biomarkers, as well as indicators of psychosocial distress (hostility, anger, depression and social support) (Krantz & McCeney, 2002;Rozanski, et al, 1999;Rozanski, et al, 2005), are associated with an increased risk of cardiovascular and metabolic disorders.…”